Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

2.31 (USD) • At close May 21, 2024
Bedrijfsnaam Oramed Pharmaceuticals Inc.
Symbool ORMP
Munteenheid USD
Prijs 2.31
Beurswaarde 93,852,759
Dividendpercentage 0%
52-weken bereik 1.67 - 4.93
Industrie Biotechnology
Sector Healthcare
CEO Mr. Nadav Kidron Esq.
Website https://www.oramed.com

An error occurred while fetching data.

Over Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for

Vergelijkbare Aandelen

Harrow Health, Inc. logo

Harrow Health, Inc.

HROW

16.49 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

64.23 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

8.74 USD

Scholar Rock Holding Corporation logo

Scholar Rock Holding Corporation

SRRK

12.27 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

2.75 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

8.135 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.49 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)